| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |